Its the active ingredient in type 2 diabetes drug Ozempic and the higher-dose obesity drug Wegovy
Endogenous GLP-1 is rapidly degraded by DPP-IV to inactive form GLP-1 (936), with half-life of approximately 2 min (Baggio and Drucker 2007)
The Right Weight Loss Treatment is Closer Than You Think Both Mounjaro and Wegovy are clinically transformative weight loss treatments that have changed what is achievable without surgery
Understanding the difference between true skin side effects and weight-lossrelated changes makes the process far less alarming and far more manageable
Understanding Gut Inflammation Gut inflammation can arise from various conditions, including inflammatory bowel disease (IBD), Crohns disease, ulcerative colitis, and leaky gut syndrome
Underlying sleep disorders Many people taking Mounjaro have excess weight, which is closely linked to sleep apnea and other sleep disorders